STOCK TITAN

The Beachbody Company, Inc. Announces Sale and Leaseback Agreement Further Strengthening The Company’s Liquidity Position

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
The Beachbody Company, Inc. (NYSE: BODi) sells its Van Nuys production facility for $6.2 million, using proceeds to prepay $5.5 million on its Term Loan. The company also amends its Term Loan reducing minimum liquidity financial covenants to improve liquidity.
Positive
  • None.
Negative
  • None.

The sale of Beachbody Company's production facility represents a strategic financial move, particularly in the context of liquidity management and debt reduction. By selling the asset for $6.2 million, which is above its net carrying value of $4.8 million, the company has realized a gain, indicating astute asset management. The subsequent leaseback arrangement ensures operational continuity while freeing up capital.

The partial prepayment of the Term Loan by $5.5 million is a significant step towards reducing the company's debt burden. This move is likely to be viewed favorably by creditors and investors as it reflects proactive financial stewardship. Furthermore, the amendment of the Term Loan to lower the minimum liquidity covenants eases the company's financial obligations, potentially improving its creditworthiness and offering more flexibility in managing its cash flows.

However, it's important to monitor the long-term implications of lease payments on the company's operating expenses. While the initial cash influx is beneficial, the lease arrangement could lead to higher fixed costs over time. Stakeholders should consider both the immediate positive impact on liquidity and the long-term financial commitments entailed by the lease.

The sale-leaseback deal can be interpreted as a signal of Beachbody's strategic pivot in a competitive health and wellness market. By liquidating a non-core asset, the company may be aiming to reinvest in its core subscription services and digital offerings, which are central to its business model. This move aligns with broader industry trends where digital and subscription-based models are gaining prominence.

From a market perspective, the transaction may also be seen as an effort to streamline operations and focus on high-growth areas. Investors and analysts typically look for such strategic decisions as indicators of a company's adaptability and forward-thinking approach. Beachbody's emphasis on improving its liquidity position suggests a strategic emphasis on financial health, which could enhance investor confidence. Nevertheless, the long-term success of this strategy will depend on the company's ability to effectively allocate the freed-up capital towards profitable growth initiatives.

The real estate aspect of the transaction, specifically the premium obtained over the net carrying value, underscores the potential undervaluation of the property on Beachbody's books or favorable market conditions for sellers. The leaseback arrangement indicates a calculated decision to maintain operational presence while benefiting from real estate capital gains.

Real estate investment analysts would evaluate the terms of the lease, such as the duration and extension options, against market rents to assess the deal's attractiveness. A five-year lease with two three-year extension options provides stability for Beachbody, but it also locks in long-term commitments. The terms of the lease, including rent escalations and other conditions, will affect the company's financial flexibility and should be scrutinized in relation to industry norms and the local real estate market's trajectory.

EL SEGUNDO, Calif.--(BUSINESS WIRE)-- The Beachbody Company, Inc. (NYSE: BODi) (“BODi” or the “Company”), a leading subscription health and wellness company, today announced that it has sold its Van Nuys production facility which had a net carrying value of $4.8 million at December 31, 2023, for $6.2 million. Simultaneous with the sale, the Company entered into a five-year lease of the facility, with two options to extend the lease for a period of three years each.

The Company used the net proceeds received from the sale to make a partial prepayment on its Term Loan of $5.5 million. The amounts related to the sale of the facility and the partial prepayment will be recorded in the quarter ended March 31, 2024. The Company also entered into an amendment of its Term Loan with its lender which (1) reduced the minimum liquidity financial covenant from $19 million to $17 million through March 31, 2024, and (2) reduced the minimum liquidity financial covenant from $24 million to $22 million from April 1, 2024 through the maturity date of the Term Loan.

Carl Daikeler, Chief Executive Officer of Beachbody, commented “The sale and leaseback transaction demonstrates our commitment to improving our liquidity position as we execute on our turnaround. We are intent on evaluating options that will optimize our balance sheet going forward.”

About BODi and The Beachbody Company, Inc.

Originally known as Beachbody, BODi has been innovating structured step-by-step home fitness and nutrition programs for 25 years such as P90X, Insanity, and 21-Day Fix, plus the first premium superfood nutrition supplement, Shakeology. Since its inception in 1999 BODi has helped over 30 million customers pursue extraordinary life-changing results. The BODi community represents millions of people helping each other stay accountable to goals of healthy weight loss, improved strength and energy, and resilient mental and physical well-being. For more information, please visit TheBeachbodyCompany.com.

Safe Harbor Statement

This press release of The Beachbody Company, Inc. ("we," "us," "our," and similar terms) contains "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are statements other than statements of historical facts and statements in future tense. These statements include but are not limited to, statements regarding our future performance and potential cost savings opportunities, including expected financial results, our business strategy, our plans, and our objectives and future operations.

Forward-looking statements are based upon various estimates and assumptions, as well as information known to us as of the date hereof, and are subject to risks and uncertainties. Accordingly, actual results could differ materially due to a variety of factors, including: our ability to effectively compete in the fitness and nutrition industries; our reliance on a few key products; market conditions and global and economic factors beyond our control; intense competition and competitive pressures from other companies worldwide in the industries in which we operate; and litigation and the ability to adequately protect our intellectual property rights. You can identify these statements by the use of terminology such as "believe", "plans", "expect", "will", "should, " "could", "estimate", "anticipate" or similar forward-looking terms. You should not rely on these forward-looking statements as they involve risks and uncertainties that may cause actual results to vary materially from the forward-looking statements. For more information regarding the risks and uncertainties that could cause actual results to differ materially from those expressed or implied in these forward-looking statements, as well as risks relating to our business in general, we refer you to the "Risk Factors" section of our Securities and Exchange Commission (SEC) filings, including those risks and uncertainties included in the Form 10-K filed with the SEC on March 16, 2023 and any subsequent Quarterly Reports on Form 10-Q or Current Reports on Form 8-K.

All forward-looking statements contained herein are based on information available to us as of the date hereof and you should not rely upon forward-looking statements as predictions of future events. The events and circumstances reflected in the forward-looking statements may not be achieved or occur. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, performance, or achievements. We undertake no obligation to update any of these forward-looking statements for any reason after the date of this press release or to conform these statements to actual results or revised expectations, except as required by law. Undue reliance should not be placed on forward-looking statements.

Investor Relations

IR@BODi.com

Source: The Beachbody Company, Inc.

The Beachbody Company sold its Van Nuys production facility for $6.2 million.

The company used the proceeds from the sale to make a partial prepayment of $5.5 million on its Term Loan.

The company amended its Term Loan to reduce the minimum liquidity financial covenant from $19 million to $17 million through March 31, 2024, and from $24 million to $22 million from April 1, 2024, to the maturity date of the loan.

Carl Daikeler is the Chief Executive Officer of Beachbody.

The ticker symbol for The Beachbody Company is BODi.
Beachbody Company Inc (The)

NYSE:BODY

BODY Rankings

BODY Latest News

BODY Stock Data

Offices of Lawyers
Professional, Scientific, and Technical Services